These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 14616726

  • 41. Localization in situ of costimulatory molecules and cytokines in B-cell non-Hodgkin's lymphoma.
    Vyth-Dreese FA, Boot H, Dellemijn TA, Majoor DM, Oomen LC, Laman JD, Van Meurs M, De Weger RA, De Jong D.
    Immunology; 1998 Aug; 94(4):580-6. PubMed ID: 9767448
    [Abstract] [Full Text] [Related]

  • 42. Immune recognition of porin and lipopolysaccharide epitopes of Salmonella typhimurium in mice.
    Singh SP, Williams YU, Klebba PE, Macchia P, Miller S.
    Microb Pathog; 2000 Mar; 28(3):157-67. PubMed ID: 10702357
    [Abstract] [Full Text] [Related]

  • 43. Insertion of host-derived costimulatory molecules CD80 (B7.1) and CD86 (B7.2) into human immunodeficiency virus type 1 affects the virus life cycle.
    Giguère JF, Bounou S, Paquette JS, Madrenas J, Tremblay MJ.
    J Virol; 2004 Jun; 78(12):6222-32. PubMed ID: 15163715
    [Abstract] [Full Text] [Related]

  • 44. Differential expression of the costimulatory molecules CD86, CD28, CD152 and PD-1 correlates with the host-parasite outcome in leprosy.
    Palermo Mde L, Trindade MÂ, Duarte AJ, Cacere CR, Benard G.
    Mem Inst Oswaldo Cruz; 2012 Dec; 107 Suppl 1():167-73. PubMed ID: 23283468
    [Abstract] [Full Text] [Related]

  • 45. Stimulation of macrophage oxygen free radical production and lymphocyte blastogenic response by immunization with porins.
    Tabaraie B, Sharma BK, Sharma PR, Sehgal R, Ganguly NK.
    Microbiol Immunol; 1994 Dec; 38(7):561-5. PubMed ID: 7968690
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. CD28/CTLA-4 and CD80/CD86 families: signaling and function.
    Slavik JM, Hutchcroft JE, Bierer BE.
    Immunol Res; 1999 Dec; 19(1):1-24. PubMed ID: 10374692
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Changes in the number of CD80(+), CD86(+), and CD28(+) peripheral blood lymphocytes have prognostic value in melanoma patients.
    Martínez-Escribano JA, Hernández-Caselles T, Campillo JA, Campos M, Frías JF, García-Alonso A, Alvarez-López MR.
    Hum Immunol; 2003 Aug; 64(8):796-801. PubMed ID: 12878358
    [Abstract] [Full Text] [Related]

  • 50. Some immunobiological properties of "Salmonella typhimurium" porins.
    Galdiero F, Tufano MA, Sommese L.
    Ann Sclavo Collana Monogr; 1986 Aug; 3(1-2):107-22. PubMed ID: 2827711
    [No Abstract] [Full Text] [Related]

  • 51. Interference with CD28, CD80, CD86 or CD152 in collagen-induced arthritis. Limited role of IFN-gamma in anti-B7-mediated suppression of disease.
    Tellander AC, Pettersson U, Runström A, Andersson M, Michaëlsson E.
    J Autoimmun; 2001 Aug; 17(1):39-50. PubMed ID: 11488636
    [Abstract] [Full Text] [Related]

  • 52. CD80 (B7-1) and CD86 (B7-2) are functionally equivalent in the initiation and maintenance of CD4+ T-cell proliferation after activation with suboptimal doses of PHA.
    Vasilevko V, Ghochikyan A, Holterman MJ, Agadjanyan MG.
    DNA Cell Biol; 2002 Mar; 21(3):137-49. PubMed ID: 12015893
    [Abstract] [Full Text] [Related]

  • 53. Interleukin-1 and interleukin-6 gene expression in human monocytes stimulated with Salmonella typhimurium porins.
    Galdiero M, Cipollaro de L'ero G, Donnarumma G, Marcatili A, Galdiero F.
    Immunology; 1995 Dec; 86(4):612-9. PubMed ID: 8567029
    [Abstract] [Full Text] [Related]

  • 54. Role of CD80 (B7.1) and CD86 (B7.2) in the immune response to an intracellular pathogen.
    Subauste CS, de Waal Malefyt R, Fuh F.
    J Immunol; 1998 Feb 15; 160(4):1831-40. PubMed ID: 9469444
    [Abstract] [Full Text] [Related]

  • 55. CD152 ligation by CD80 on T cells is required for the induction of unresponsiveness by costimulation-deficient antigen presentation.
    Chai JG, Vendetti S, Amofah E, Dyson J, Lechler R.
    J Immunol; 2000 Sep 15; 165(6):3037-42. PubMed ID: 10975813
    [Abstract] [Full Text] [Related]

  • 56. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
    Mauri D, Wyss-Coray T, Gallati H, Pichler WJ.
    J Immunol; 1995 Jul 01; 155(1):118-27. PubMed ID: 7541409
    [Abstract] [Full Text] [Related]

  • 57. Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation.
    Vandenborre K, Van Gool SW, Kasran A, Ceuppens JL, Boogaerts MA, Vandenberghe P.
    Immunology; 1999 Nov 01; 98(3):413-21. PubMed ID: 10583602
    [Abstract] [Full Text] [Related]

  • 58. Lipopolysaccharide-dependent down-regulation of CD27 expression on T cells activated with superantigen.
    Kai K, Rikiishi H, Sugawara S, Takahashi M, Takada H, Kumagai K.
    Immunology; 1999 Oct 01; 98(2):289-95. PubMed ID: 10540229
    [Abstract] [Full Text] [Related]

  • 59. B cell-driven HIV type 1 expression in T cells: an essential role of CD86 costimulatory molecule.
    Krzysiek R, Lefèvre EA, Legendre C, Treton D, Dormont D, Galanaud P, Gras G, Richard Y.
    AIDS Res Hum Retroviruses; 1998 Jul 20; 14(11):989-97. PubMed ID: 9686645
    [Abstract] [Full Text] [Related]

  • 60. CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A.
    Mukherjee S, Ahmed A, Nandi D.
    J Leukoc Biol; 2005 Jul 20; 78(1):144-57. PubMed ID: 15788440
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.